According to researchers, an interaction between host microRNA and SARS-CoV-2 could be responsible for the range of disease severities.
List view / Grid view
Epstein-Barr virus (EBV)
Amid the rush to develop an effective vaccine against COVID-19, antibody therapy has become a major strategy to ameliorate and treat cases of severe disease. Armed with the capacity to neutralise pathogens and orchestrate the immune system, promising antibody candidates for multiple viral indications, including HIV, continue to emerge. Technology…